Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Exalenz Bioscience Launches Automated BreathID® Hp Lab Urea Breath Testing System For Helicobacter pylori Detection

Exalenz Bioscience
Posted on: 17 Aug 17

Exalenz Bioscience (TASE: EXEN) expanded its BreathID Hp urea breath testing product line by introducing the new BreathID Hp Lab system at the recent 2017 annual scientific meeting of the American Association for Clinical Chemistry (AACC) in San Diego. The BreathID Hp systems are intuitive and time-efficient products that detect active carcinogenic H. pylori bacterial infection. Building on the success and technology of the point-of-care BreathID Hp, the new BreathID Hp Lab system provides an automated solution for batch test analysis.

“Clinical guidelines and insurance policies highly recommend urea breath testing for H. pylori infection management, and these guidelines continue to expand. Recently as an example, updated clinical guidelines for management of dyspepsia recommends non-invasive H. pylori screening for all dyspepsia symptomatic patients under the age of 60,” stated Gavin Doree, Vice President of Sales and Marketing for Exalenz Bioscience. “With these ever-growing clinical needs in mind, the BreathID Hp Lab system allows laboratories to confidently offer physicians advanced diagnostic accuracy for testing their patients for H. pylori – all the while having cost-effective and intuitive efficiency in their testing operations.”

For over a decade, Exalenz Bioscience has provided point-of-care H. pylori testing technology with the market-leading BreathID Hp urea breath test system. With over 99% sensitivity and specificity for H. pylori detection, the BreathID Hp system’s clinical accuracy and patient friendly test method proved to be a smarter and better non-invasive diagnostic choice than the outdated blood antibody test (could not accurately test for active H. pylori infection) or stool antigen test (lack of patient compliance).

Building on this clinically proven diagnostic technology, the BreathID Hp Lab system was engineered with today’s laboratories and clinics in mind by intuitively automating lab operations that maximize lab throughput and management, minimize human error, and provide cost-effectiveness. With H. pylori – a known Group 1 carcinogen – continuing to be the world’s most common bacterial infection causing many gastrointestinal issues, the imperative need of laboratories to provide physicians a clinically proven – yet cost-effective and accurate diagnostic solution for H. pylori testing – is met with the simple-to-use but clinically powerful BreathID Hp Lab system.

For more information on the new BreathID Hp Lab system, BreathID Hp point-of-care device, or Exalenz Bioscience the company, vist, telephone 1-888-EXALENZ or email the company at

View source version on

Business Wire

Last updated on: 17/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.